Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection

Tick-borne encephalitis: One vaccine protects against multiple flaviviruses Prior exposure to tick-borne encephalitis virus confers immunity to distinct, but genetically related, significant human pathogens. The tick-borne encephalitis complex comprises multiple ‘flaviviruses’; however, a licensed v...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alexander J. McAuley, Bevan Sawatsky, Thomas Ksiazek, Maricela Torres, Miša Korva, Stanka Lotrič-Furlan, Tatjana Avšič-Županc, Veronika von Messling, Michael R. Holbrook, Alexander N. Freiberg, David W. C. Beasley, Dennis A. Bente
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
Acceso en línea:https://doaj.org/article/a72ff5e911e648228cdfd515419ac629
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:a72ff5e911e648228cdfd515419ac629
record_format dspace
spelling oai:doaj.org-article:a72ff5e911e648228cdfd515419ac6292021-12-02T11:50:55ZCross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection10.1038/s41541-017-0009-52059-0105https://doaj.org/article/a72ff5e911e648228cdfd515419ac6292017-03-01T00:00:00Zhttps://doi.org/10.1038/s41541-017-0009-5https://doaj.org/toc/2059-0105Tick-borne encephalitis: One vaccine protects against multiple flaviviruses Prior exposure to tick-borne encephalitis virus confers immunity to distinct, but genetically related, significant human pathogens. The tick-borne encephalitis complex comprises multiple ‘flaviviruses’; however, a licensed vaccine only exists for one: tick-borne encephalitis virus (TBEV). Alexander McAuley, of the University of Texas Medical Branch, USA, and collaborators tested human serum samples from donors who had either received the TBEV vaccine, been infected with the virus naturally, or had contracted the virus despite prior vaccination. The team tested the sera against six genetically related flaviviruses, looking for antibodies that indicate viral immunity. The results showed that TBEV exposure induce production of antibodies that inhibit other flaviviruses, the efficacy of which decreases as the genetic variation from TBEV increases. Additionally, sera from infected individuals generated more antibodies than sera from vaccinated donors. This study provides an insight into the relationship between genetic similarity and vaccine cross-protection.Alexander J. McAuleyBevan SawatskyThomas KsiazekMaricela TorresMiša KorvaStanka Lotrič-FurlanTatjana Avšič-ŽupancVeronika von MesslingMichael R. HolbrookAlexander N. FreibergDavid W. C. BeasleyDennis A. BenteNature PortfolioarticleImmunologic diseases. AllergyRC581-607Neoplasms. Tumors. Oncology. Including cancer and carcinogensRC254-282ENnpj Vaccines, Vol 2, Iss 1, Pp 1-10 (2017)
institution DOAJ
collection DOAJ
language EN
topic Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
spellingShingle Immunologic diseases. Allergy
RC581-607
Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282
Alexander J. McAuley
Bevan Sawatsky
Thomas Ksiazek
Maricela Torres
Miša Korva
Stanka Lotrič-Furlan
Tatjana Avšič-Županc
Veronika von Messling
Michael R. Holbrook
Alexander N. Freiberg
David W. C. Beasley
Dennis A. Bente
Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
description Tick-borne encephalitis: One vaccine protects against multiple flaviviruses Prior exposure to tick-borne encephalitis virus confers immunity to distinct, but genetically related, significant human pathogens. The tick-borne encephalitis complex comprises multiple ‘flaviviruses’; however, a licensed vaccine only exists for one: tick-borne encephalitis virus (TBEV). Alexander McAuley, of the University of Texas Medical Branch, USA, and collaborators tested human serum samples from donors who had either received the TBEV vaccine, been infected with the virus naturally, or had contracted the virus despite prior vaccination. The team tested the sera against six genetically related flaviviruses, looking for antibodies that indicate viral immunity. The results showed that TBEV exposure induce production of antibodies that inhibit other flaviviruses, the efficacy of which decreases as the genetic variation from TBEV increases. Additionally, sera from infected individuals generated more antibodies than sera from vaccinated donors. This study provides an insight into the relationship between genetic similarity and vaccine cross-protection.
format article
author Alexander J. McAuley
Bevan Sawatsky
Thomas Ksiazek
Maricela Torres
Miša Korva
Stanka Lotrič-Furlan
Tatjana Avšič-Županc
Veronika von Messling
Michael R. Holbrook
Alexander N. Freiberg
David W. C. Beasley
Dennis A. Bente
author_facet Alexander J. McAuley
Bevan Sawatsky
Thomas Ksiazek
Maricela Torres
Miša Korva
Stanka Lotrič-Furlan
Tatjana Avšič-Županc
Veronika von Messling
Michael R. Holbrook
Alexander N. Freiberg
David W. C. Beasley
Dennis A. Bente
author_sort Alexander J. McAuley
title Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
title_short Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
title_full Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
title_fullStr Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
title_full_unstemmed Cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
title_sort cross-neutralisation of viruses of the tick-borne encephalitis complex following tick-borne encephalitis vaccination and/or infection
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/a72ff5e911e648228cdfd515419ac629
work_keys_str_mv AT alexanderjmcauley crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT bevansawatsky crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT thomasksiazek crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT maricelatorres crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT misakorva crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT stankalotricfurlan crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT tatjanaavsiczupanc crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT veronikavonmessling crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT michaelrholbrook crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT alexandernfreiberg crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT davidwcbeasley crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
AT dennisabente crossneutralisationofvirusesofthetickborneencephalitiscomplexfollowingtickborneencephalitisvaccinationandorinfection
_version_ 1718395182475378688